From: Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis
LncRNAs | Source (Tissues and/or cells) | Expression in patients | Related genes | Experimental data | Function | References |
---|---|---|---|---|---|---|
HOTAIR | Breast cancer, OSCC, GC, Nasopharyngeal carcinoma, ESCC, HCC, NSCLC, EOC, PCa, Colon cancer | Increased | PRC2, LSD1, H3K4, H3K27, HOXD10, PRG1, PCDH, WIF-1, Wnt/β-catenin signaling, MMP-9, VEGF, RBM38, EMT-related genes | Promote cell proliferation, increase invasion and metastasis, advanced clinical stage, bad prognosis | OG | |
MALAT1 | Glioblastoma, Breast cancer, Lung cancer, ESCC, Pancreatic cancer, Kidney cancer, Bladder cancer, PCa, CRC, GC | Increased | WIF-1, N-Myc, JMJD1A, ATM-CHK2 pathway, p21 and p27, B-MYB, EMT-related genes, TGF-β, AKAP-9, SFPQ, PTBP2, Wnt/β-catenin signaling, miR-9, MEK/extracellular signaling | Increase tumorigenicity, promote cell proliferation, increase invasion and metastasis, advanced clinical stage, bad prognosis, inhibit cell cycle and apoptosis | OG | |
H19 | GC, Ovarian cancer, Endometrial cancer, Bladder cancer, Epithelial cell | Increased | miR-675, ISM1, CALN1, let-7, HMGA2, c-Myc, Hmga2, Igf2bp3, EZH2, Wnt/β-catenin signaling, HGF/SF | Promote cell proliferation, increase invasion and metastasis | OG | |
BANCR | Malignant melanoma, Lung cancer, Retinoblastoma, CRC | Increased | Â | Promote cell proliferation, increase invasion and metastasis, advanced clinical stage | OG | |
CCAT1 & CCAT2 | HCC, GC, Breast cancer | Increased | let-7, HMGA2, c-Myc, TPM1, BTG2 | Promote cell proliferation, increase invasion and metastasis | OG | |
UCA1 | TSCC, ESCC, CRC, Bladder cancer, Malignant melanoma | Increased | Â | Promote cell proliferation, increase invasion and metastasis, inhibit cell cycle and apoptosis, advanced clinical stage, poor prognosis | OG | |
FOXCUT | BLBC, OSCC, ESCC | Increased | FOXC1 | Promote cell proliferation and colony formation, increase invasion and metastasis, advanced clinical stage | OG | |
AFAP1-AS1; HNF1A-AS1 | EAC | Increased | Â | Increase tumorigenicity | OG | |
PEG10 | Esophageal cancer cells | Increased | Â | Inhibit apoptosis, increase invasion | OG | [80] |
SPRY4-IT1; TUG1 | ESCC | Increased | MAPK signaling pathway | Promote cell proliferation, increase invasion and metastasis, inhibit apoptosis, advanced clinical stage, poor prognosis | OG | |
SDMGC | GC | Increased | TRIM16 | Promotes invasion and metastasis | OG | [84] |
GAPLINC | GC | Increased | CD44 | Promotes metastasis | OG | [85] |
91H | CRC | Increased | Â | Promotes migration, invasion and distant metastasis, poor prognosis | OG | [86] |
ZXF1 | Lung adenocarcinoma | Increased | Â | Promotes migration, invasion and metastasis | OG | [87] |
GHSROS; CARLo-5; AF118081 | NSCLC | Increased | Â | Promote cell proliferation, increase invasion and metastasis | OG | |
XIST | GSCs | Increased | miR-152 | Promote cell proliferation, invasion, metastasis | OG | [91] |
HIT; linc-ROR | Breast cancer | Increased | TGF-β signaling, EMT-related genes, certain miRNAs | Increase tumorigenicity, promote cell proliferation, increase invasion and metastasis | OG | |
Loc554202 | Breast cancer | Increased | LATS2, TNFAIP1 | Promote cell proliferation, increase invasion and metastasis, inhibit apoptosis, advanced clinical stage | OG | [94] |
BCAR4 | Breast cancer | Increased | SNIP1, PNUTS, CCL21 | Promotes cell metastasis | OG | [95] |
RCCRT1 | RCC | Increased | Â | Promote invasion and metastasis, advanced clinical stage | OG | [96] |
linc-UBC1; UCA1a (CUDR) | Bladder cancer | Increased | Â | Promote tumorigenicity and colony formation, promote cell proliferation, increase invasion and metastasis, advanced clinical stage, bad prognosis | OG | |
SChLAP1; linc00963; PCGEM1; PCAT18 | PCa | Increased | EGFR signaling, p-AKT, miR-145, caspase 3/7 | Promote tumorigenicity, promote cell proliferation, increase invasion and metastasis, inhibit apoptosis | OG | |
EBIC | Cervical cancer | Â | EZH2, E-cadherin | Promote invasion and metastasis | OG | [103] |
HOST2; TC0101441 | Ovarian cancer | Increased | let-7b | Promote cell proliferation, increase invasion and metastasis | OG | |
ZNF300P1 | Ovarian cancer | Decreased | Â | Promote cell proliferation and colony formation, increase metastasis | OG | [105] |